NeuCode SILAC and mass spectrometry proteomics analysis towards 1-day post L4 adult hermaphrodites after 6 hours of treatments by 1uM ascaroside ascr#2 or ascr#5.
NeuCode SILAC and mass spectrometry proteomics analysis towards 1-day post L4 adult hermaphrodites after 6 hours of treatments by 1uM ascaroside ascr#2 or ascr#5.
NeuCode SILAC and mass spectrometry proteomics analysis towards 1-day post L4 adult hermaphrodites after 6 hours of treatments by 1uM ascaroside ascr#2 or ascr#5.
NeuCode SILAC and mass spectrometry proteomics analysis towards 1-day post L4 adult hermaphrodites after 6 hours of treatments by 1uM ascaroside ascr#2 or ascr#5.
NeuCode SILAC and mass spectrometry proteomics analysis towards 1-day post L4 adult hermaphrodites after 6 hours of treatments by 1uM ascaroside ascr#2 or ascr#5.
NeuCode SILAC and mass spectrometry proteomics analysis towards 1-day post L4 adult hermaphrodites after 6 hours of treatments by 1uM ascaroside ascr#2 or ascr#5.
NeuCode SILAC and mass spectrometry proteomics analysis towards 1-day post L4 adult hermaphrodites after 6 hours of treatments by 1uM ascaroside ascr#2 or ascr#5.
NeuCode SILAC and mass spectrometry proteomics analysis towards 1-day post L4 adult hermaphrodites after 6 hours of treatments by 1uM ascaroside ascr#2 or ascr#5.
NeuCode SILAC and mass spectrometry proteomics analysis towards 1-day post L4 adult hermaphrodites after 6 hours of treatments by 1uM ascaroside ascr#2 or ascr#5.
In order to assess mRNA changes in dyf-1(mn335) compared to wildtype (N2) we performed a Microarray analysis with 4 biological replicates at day 1 of adulthood.